Will Competition and Innovation Lower Drug Prices?

Grace-Marie Turner, President of Galen Institute, writes in the Forbes’ contributor column why federal taxes will not bring down drug prices, the solution is more competition and innovation.  Read her column here…

 Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.